The Neuroprotective Effect of Ursolic Acid Associated with Inflammation Factors: IL-10, IL β after the Induction of Severe Traumatic Brain Injury in Rats
Journal Title: The 1st Annual Meeting of Georgian Center for Neuroscience Research - Year 2020, Vol 2, Issue 20
Abstract
Introduction: Ursolic Acid (UA) is a Penta cyclic triterpene compound which Reduces cerebral edema and improves neurological deficits after TBI, leading to increased Nrf2 protein and increased expression of reductase-1 and cooxygenase enzymes, which is suggested to play a neuroprotective role. Therefore, in this study, we investigated the effects of neuroprotective UA after induction of brain inflammation in rats. Materials and methods: The male Albino Westar rats received different doses of Ursolic Acid (25, 50, 100 mg/kg, I.P) UA .All animals were intubated before surgery. In the TBI groups, diffuse TBI was induced by Marmarou method using a TBI induction device. The severe TBI was induced using a weight 450gr in the sham groups, all stages of induction of TBI were performed except dropping weight on the head. The disruption of Blood brain- barrier (BBB) was evaluated 6h Post-TBI. The neurologic score (VCS) and brain water content, the beam-walk –balance task (WB) were determined before trauma, on trauma time(D0), and 1Day (D1) and 2 Days (D2) and 3 Days (D3) After TBI anaesthetized animals CSF collection from cisterna magna and then were sacrificed and the brain was removed and then analysis MMP-9 with Elisa assay. Results: Our results showed that traumatic brain injury leads to significant brain edema and disrupt of blood brain-barrier and neurological defect and vestibulomotor dysfunction in the rats brain and decreases MMP9 in CSF. UA (25,50mg/kg) could attenuate brain edema, improve BBB and vestibulomotor dysfunction in compare with TBI control group (P<0.001) but in 25 mg/kg dose results were better. Discussion: Our findings showed that UA has a prominent role in TBI outcome’s and perhaps protects neurons through modulating inflammatory and antioxidant pathways so reduces the level of IL-1 β and increases the level of IL-10 in CSF.
Authors and Affiliations
Fakhroddin Alemi, Ali Siahposht-Khachaki, Ali Alinejad-Naddafi, Davood Farzin
Keywords
Related Articles
- EP ID EP677916
- DOI 10.29088/GCNR-2020.07
- Views 275
- Downloads 0
Computational Lncrna – Mirna Interaction Analyses in Epilepsy Syndrome
Epilepsy is a neurological disorder associated to Central Nervous System. The seizures of epilepsy anomaly accurse due to the electrical activity disruption in the brain. Almost 80% of epilepsy cases are the results of...
Effect of Stem Cell to Treat Amyotrophic Lateral Sclerosis
Background and objective: Amyotrophic lateral sclerosis (ALS), known as motor neuron disease, is characterized by the degeneration of both upper (the nerve cells in the brain) and lower motor neurons (the brain stem nuc...
The Comparison of Executive Functions in Addicts and Patients Under Buprenorphine Maintenance Treatment (BMT)
Introduction: Buprenorphine, a partial opioid agonist of the µ-receptor, is one of the most important developments in pharmacotherapy for opioid addiction. However, there are some clinical and empirical evidence for exe...
Contribution of Nitric Oxide in Initiation of Cortical Spreading Depression in Ischemic Stroke
Nitric oxide (NO), the most convincing gaseous signaling molecule in vertebrates, was increasingly recognized as one of the most versatile and unique molecules mediating such diverse physiological functions as the maint...
Beneficial Effects of Japanese Sake Yeast Supplement on Depressive-Like Behaviors in a Rat Model of Global Cerebral Ischemia/Reperfusion
Background: Stroke is known to be one of the most frequent causes of mortality, responsible for high rates of death and disability around the world. Antioxidant agents can reduce ischemic nerve damage by eliminating fre...